Trademark: 90381096
Word
ALIMENTIV
Status
Registered
Status Code
700
Status Date
Tuesday, November 8, 2022
Serial Number
90381096
Registration Number
6891764
Registration Date
Tuesday, November 8, 2022
Mark Type
3000
Filing Date
Monday, December 14, 2020
Published for Opposition
Tuesday, August 23, 2022

Trademark Owner History
Alimentiv Inc. - Original Registrant

Classifications
9 Computers, peripheral hardware components, namely, blank external hard drives, blank flash drives, and video cables; video capture devices, namely, signal processors, video receivers and video recorders for converting signals from endoscopy machines to USB for storing on computers; Recorded video recording software, and downloadable video recording software configured according to study protocol requirements for receiving, storing and securely sending clinical study data, obtained from using imaging endoscopic procedures, over the Internet to a secure website
35 Business project management services, namely, project management of clinical studies, recruitment and selection of clinical study sites and investigators, management of clinical study sites and clinical monitoring, managing relationships between vendors and subcontractors, organization and planning of meetings, workshops and events; Records management services, namely, document indexing for others, specifically, coordinating and controlling flow of electronic and paper documents; Data management services for use in pharmaceutical drug development, namely, preparation of Case Report Forms (CRFs), Collection and compilation of information into computer databases in the field of clinical studies; Compilation and provision of statistical and biostatistical information; Medical coding services for others in the nature of coding clinical trial data for purposes of medical science and regulatory review and approvals
45 Regulatory submission management, namely, assisting others with preparing and filing applications for new drugs with government regulatory bodies, submission planning and life cycle management of clinical trial applications to Competent Authorities, Ethics Committees and Regulatory Agencies, pre-approval submissions, submission of supplements, amendments and variations applications, submission publishing and dossier compilation in electronic common technical document or common technical document formats, annual reports, paper submissions management and submission archival
44 Medical imaging services; Medical diagnostic testing, monitoring and reporting services; Medical imaging services, namely, electronic medical imaging support services for use in assessing patient health in clinical trials, namely, reviewing and scoring electronic medical images, including video images, of patients supplied by others; Medical imaging services, namely, histopathology support services for reviewing and scoring tissue sample images provided by others; Consulting services in the field of medical imaging, namely, magnetic resonance support services for reviewing and scoring magnetic resonance images provided by others; Medical services, namely, endoscopy support services in the field of reviewing and scoring endoscopic images provided by others
42 Technical writing, namely, medical writing services for developing medical protocols, clinical study reports, investigator brochures, safety reports, informed consent forms, meeting abstracts, posters, manuscripts, study charts, manuals and literature reviews; Providing an Internet website portal featuring clinical study and clinical trial management system tools; Electronic storage of files and documents, secure storage of electronic and paper documents; File sharing services, namely, providing a website featuring technology enabling users to upload and download electronic files, namely, complete and inspection-ready trial management files; Electronic storage services for archiving databases, images and other electronic data in the field of trial management files (TMF), TMF setup, archiving and management of TMP files through lifecycle of clinical study; Conducting scientific research, namely, biostatistics and statistical programming, protocol development of sample size and power calculations, randomization schedules, statistical analysis plans, statistical programming and validation in statistical analysis system, statistical analyses, interpretation and reporting of data for clinical trial reports and publications, statistical and strategic consulting for product development, interim analysis for early decision-making, database integration, New Drug Application (NDA) ready data listings, regulatory submission compliant datasets, thought leadership and operational experience with study data tabulation model and analysis data model regulatory submission standards, integrated safety and efficacy summaries, adaptive design consulting and simulation support, translational research support data monitoring board management and support; Medical research services, namely, medical monitoring and investigator site monitoring in the field of medical review of clinical study materials, preparation of medical monitoring and safety plans, continuous trial oversight via patient level and safety data review, subject eligibility support for investigators, medical support to sites and study teams for interpretation of study protocol, consultation on potential safety issues and medical concerns and 24/7 medical monitor coverage; Pharmaceutical drug development services in the field of drug safety, specifically, processing adverse events from clinical trials, preparing Development Safety Update Reports (DSURs) and other aggregate reports, performing signal detection and benefit-risk assessments, preparing safety management plans and preparing medical monitoring plans; Providing quality assurance services in the field of clinical trials, namely, quality assistance documentation, such as Standard Operating Procedures (SOPs) and work instructions, internal system reviews, site audits, vendor assessments; Medical research services in the field of pharmacology, namely, dose simulation, selection and optimization, selection of biomarkers and endpoints, optimization of trial design, population pharmacokinetic and pharmacodynamic modeling, exposure response modeling; Medical research services in the field of translational medicine, namely, immunohistochemistry, flow cytometry, transcriptomics, proteomics, microbiome study; Providing medical and scientific research information in the field of clinical trials, namely, the design of clinical trials and outcome measures for studying human diseases, or for studying or testing drugs, devices or methods of medical treatment on humans in relation to diseases; Conducting clinical trials for others which study human diseases, or study or test drugs, devices or methods of medical treatment on humans in relation to diseases; Custom computer programming of imaging adjudication and computer systems integration of eligibility data with Interactive Response Technology (IRT); Computer database design and implementation for data collection, data storage, data management, data analysis, and data validation for use in pharmaceutical drug development; Compilation and provision of clinical study data, namely, compiling data for research purposes in the field of medical science and medical consultancy
The mark consists of the word "ALIMENTIV" in stylized form with the letter "T" appearing with four connected circles at the top.

Trademark Events
Nov 8, 2022
Notice Of Registration Confirmation Emailed
Nov 8, 2022
Registered-Principal Register
Aug 23, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 23, 2022
Published For Opposition
Aug 3, 2022
Notification Of Notice Of Publication E-Mailed
Jul 16, 2022
Approved For Pub - Principal Register
Jul 6, 2022
Teas/Email Correspondence Entered
Jul 6, 2022
Correspondence Received In Law Office
Jul 6, 2022
Assigned To Lie
Jun 21, 2022
Teas Response To Suspension Inquiry Received
Jun 13, 2022
Notification Of Letter Of Suspension E-Mailed
Jun 13, 2022
Letter Of Suspension E-Mailed
Jun 13, 2022
Suspension Letter Written
Jun 13, 2022
Examiner's Amendment Entered
Jun 13, 2022
Notification Of Examiners Amendment E-Mailed
Jun 13, 2022
Examiners Amendment E-Mailed
Jun 13, 2022
Examiners Amendment -Written
May 19, 2022
Teas/Email Correspondence Entered
May 18, 2022
Correspondence Received In Law Office
May 18, 2022
Teas Response To Office Action Received
Dec 7, 2021
Notification Of Non-Final Action E-Mailed
Dec 7, 2021
Non-Final Action E-Mailed
Dec 7, 2021
Non-Final Action Written
Oct 29, 2021
Teas/Email Correspondence Entered
Oct 28, 2021
Correspondence Received In Law Office
Oct 28, 2021
Teas Response To Office Action Received
Jun 15, 2021
Notification Of Non-Final Action E-Mailed
Jun 15, 2021
Non-Final Action E-Mailed
Jun 15, 2021
Non-Final Action Written
Jun 4, 2021
Assigned To Examiner
Feb 23, 2021
Notice Of Design Search Code E-Mailed
Feb 22, 2021
New Application Office Supplied Data Entered In Tram
Dec 17, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24